CCR8 drugs for Non-Small Cell Lung Cancer

5 tracked CCR8 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the CCR8 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.

1 Phase 22 Phase 12 preclinical / unstaged

Head-to-head evidence: AMG 355 vs Azirkitig · AMG 355 vs Azirkitug · AMG 355 vs Enzelkitug · AMG 355 vs Imzokitug

The roster

← all CCR8 drugs